Xoma | XOMA - Ordinary Share Capital


Xoma reported $87K in Ordinary Share Capital for its fiscal quarter ending in June of 2024.



Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Agenus USD 38.52M 3.2M Mar/2026
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
Ardelyx USD 246.97M 2.62M Mar/2026
aTyr Pharma USD 62.99M 46.35M Mar/2026
BioMarin Pharmaceutical USD 193.54M 267K Jun/2026
Celldex Therapeutics USD 78.5M 11.93M Jun/2026
Curis USD 2M 10.93M Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Emergent BioSolutions USD 100K 0 Jun/2023
Incyte USD 200.98M 1.03M Jun/2026
MacroGenics USD 63.56M 241K Mar/2026
Novartis USD 1.9B 7.38M Jun/2026
Novartis USD 1.91B 60K Mar/2026
Pfizer USD 5.7B 0 Jun/2026
Prothena USD 53.08M 756K Mar/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026